Skip to content

Development of an Algorithm for Predicting Post-Stroke Sarcopenia and Long-Term Outcomes After Stroke

Development of Multimodal Explainable AI (XAI) using Imaging and Blood Biomarkers for Predicting Post-Stroke Sarcopenia and Long-term Prognosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0012312
Enrollment
140
Registered
2026-07-22
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kyung Hee University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged 50 years or older with acute stroke Patients who underwent brain MRI or CT within 1 week of stroke onset Patients who are able to undergo handgrip strength testing and body composition assessment using InBody S10 bioelectrical impedance analysis (BIA) within 1 month after stroke onset Patients who are available for follow-up evaluations at 1, 3, and 12 months after stroke onset through outpatient visits or telephone interviews Patients who provide written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Patients with severe pre-stroke disability (modified Rankin Scale > 2) Patients with conditions that may independently affect sarcopenia, including end-stage cancer, dialysis-dependent chronic kidney disease, or neuromuscular disorders Patients with contraindications to bioelectrical impedance analysis (BIA), such as pacemakers or implantable cardioverter-defibrillators Patients with anatomical abnormalities of the temporalis muscle or a history of temporalis muscle surgery Patients with poor-quality MRI or CT images that preclude accurate measurement of temporalis muscle thickness Pregnant women or women for whom pregnancy cannot be excluded

Design outcomes

Primary

MeasureTime frame
Presence of post-stroke sarcopenia at 1 month after stroke onset

Secondary

MeasureTime frame
Hospital readmission;Mortality;Functional disability assessed by the Modified Rankin Scale (mRS)

Countries

Korea, Republic of

Contacts

Public ContactYunjung Rho

KyungHee University Medical Center

allyrho@naver.com+82-2-958-8561

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Aug 10, 2026